Woman aging is associated with hormonal changes affecting her intimate sphere. Among their consequence is withering dryness, a chronic and progressive condition affecting up to 93% of postmenopausal women that can lead to irritation and pain, and that can be associated with itching, burning, and painful intercourse.
Maybe you already heard about vaginal moisturizer, lubricant, estrogen preparations, laser or other treatments to counteract this problem. The most innovative way to restore vaginal lubrication and say goodbye to withering dryness and associated painful intercourse is GynSkill, the treatment based on stem cells offered by Bioscience Institute. Let’s discover how it works.
Stem cells in female rejuvenation
Stem cells are cells capable of tissue regeneration. In particular, Mesenchymal Stem Cells (MSCs) are widely utilized in regenerative medicine, allowing the treatment of several age-related conditions. Adipose tissues is among the best sources of MSCs, and Adipose-Derived Stem Cells (ADSCs) properties can be exploited also for female rejuvenation treatments, such as those against withering dryness. In fact, tissue elasticity is related to collagen and elastin production, and ADSCs promote new collagen and elastin synthesis. Moreover, this cells provide regenerative factors that improve body response to the biological damage associated with aging.
GynSkill, based on ADSCs injection, allows a totally natural treatment of withering dryness. In fact, stem cells are obtained from the patient’s own adipose tissue. The procedure is fast and painless, requiring the collection of only 20 cc of fat in outpatient setting. Stem cells are then extracted from collected fat and expanded at Bioscience’s laboratories to obtain the dose required for withering dryness treatment. Once injected, expanded cells release specific growth factors and promote tissue regeneration.
Stem cell treatment advantages
GynSkill stem cell-based treatment does not require the use of foreign component or general anesthesia, reducing the risks associated with invasive surgical procedures and allowing the rapid return to daily activities. Improvements progressively increase over time; pain reduction is obtained in just 1 months and become dramatically evident after 1 year. Results are maintained in the long term, with pain reduction and sexual function improvement documented 2 years after treatment.
Moreover, GynSkill counteract also vaginal flaccidity and urinary incontinence, and it is effective at every age. That is why it is recommended also for women suffering from urogenital complaints other than age-related (e.g. surgery-related and idiopathic).
Stem cell treatment is the evolution of standardized female rejuvenation therapies, and a valuable alternative to older treatments. For more information visit GynSkill webpage or feel free to contact us at +971 (0)4 375 7220..
References
- Angelou K et al. The Genitourinary Syndrome of Menopause: An Overview of the Recent Data. Cureus. 2020 Apr; 12(4): e7586. doi: 10.7759/cureus.7586
- Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician. 2000 May 15;61(10):3090-6. PMID: 10839558
- Onesti MG et al. The Use of Human Adipose-Derived Stem Cells in the Treatment of Physiological and Pathological Vulvar Dystrophies. Stem Cells Int. 2016; 2016: 2561461. doi: 10.1155/2016/2561461
